Association between dynapenic obesity and risk of cardiovascular disease: The Hisayama study

被引:4
作者
Setoyama, Yu [1 ,2 ]
Honda, Takanori [1 ,3 ]
Tajimi, Takahiro [1 ,2 ]
Sakata, Satoko [1 ,3 ,4 ]
Oishi, Emi [1 ,3 ,4 ]
Furuta, Yoshihiko [1 ,4 ]
Shibata, Mao [1 ,3 ]
Hata, Jun [3 ,5 ]
Kitazono, Takanari [3 ,4 ]
Nakashima, Yasuharu [2 ]
Ninomiya, Toshiharu [1 ,3 ]
机构
[1] Kyushu Univ, Grad Sch Med Sci, Dept Epidemiol & Publ Hlth, Fukuoka, Japan
[2] Kyushu Univ, Grad Sch Med Sci, Dept Orthopaed Surg, Fukuoka, Japan
[3] Kyushu Univ, Ctr Cohort Studies, Grad Sch Med Sci, 3-1-1,Maidashi,Higashi Ku, Fukuoka 8128582, Japan
[4] Kyushu Univ, Grad Sch Med Sci, Dept Med & Clin Sci, Fukuoka, Japan
[5] Kyushu Univ, Grad Sch Med Sci, Dept Hlth Care Adm & Management, Fukuoka, Japan
关键词
Body mass index; Cardiovascular disease; Dynapenic obesity; Handgrip strength; SARCOPENIC-OBESITY; OLDER-ADULTS; MUSCLE MASS; MORTALITY; POPULATION; DEFINITION; DIAGNOSIS; STRENGTH; UPDATE; HEALTH;
D O I
10.1002/jcsm.13564
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Background Dynapenic obesity is a condition characterized by high adiposity levels combined with muscle dysfunction. Although high adiposity and muscle loss/dysfunction are thought to synergistically increase the risk of cardiovascular disease (CVD), few studies have addressed the association between dynapenic and sarcopenic obesity and CVD. We aimed to investigate the association of dynapenic obesity with incident CVD events using the data from a population-based prospective longitudinal study in Japan. Methods A total of 2490 community-dwelling Japanese aged 40-79 years (42.5% males, mean age 57.7 +/- 10.6 years) without a history of CVD were followed up for a median of 24 years. Handgrip strength was classified as low, medium, or high by age- and sex-specific tertiles. Body mass index (BMI) levels were categorized as lean (<18.5 kg/m2), normal (18.5-24.9 kg/m2), or obese (>= 25.0 kg/m2). Dynapenic obesity was defined as having both low handgrip strength and obesity. The outcomes were defined as the first-ever development of CVD (defined as stroke or coronary heart disease). The hazard ratios (HRs) and their 95% confidence intervals (CIs) for the development of CVD were estimated using a Cox proportional hazards model, in which participants with high handgrip strength and normal BMI were used as a reference group. Mediation analyses used serum high-sensitivity C-reactive protein (hs-CRP) and homeostatic model assessment for insulin resistance (HOMA-IR) as mediators. Results During the follow-up period, 482 participants developed CVD events (324 cases of stroke and 209 of coronary heart disease). The multivariable-adjusted risk of CVD increased significantly among participants with dynapenic obesity compared with the reference group (HR 1.49, 95% CI 1.03-2.17). An analysis by age groups showed a further increase in the risk of CVD among participants with dynapenic obesity aged less than 65 years (HR 1.66, 95% CI 1.04-2.65). In mediation analyses for participants aged less than 65 years, serum hs-CRP was shown to be a significant mediator explaining 13.8% of the association between dynapenic obesity and the development of CVD, while HOMA-IR explained 12.2% of this relationship. Conclusions Dynapenic obesity was a significant risk factor for the development of CVD in a general Japanese population. This association was more pronounced among those aged <65 years. Inflammation, and possibly glucose metabolism, might partly mediate this association. Our findings suggest that preventing muscle dysfunction as well as appropriate weight control, especially in middle-age, are important for preventing the development of CVD.
引用
收藏
页码:2338 / 2348
页数:11
相关论文
共 41 条
  • [1] Compendium of Physical Activities: an update of activity codes and MET intensities
    Ainsworth, BE
    Haskell, WL
    Whitt, MC
    Irwin, ML
    Swartz, AM
    Strath, SJ
    O'Brien, WL
    Bassett, DR
    Schmitz, KH
    Emplaincourt, PO
    Jacobs, DR
    Leon, AS
    [J]. MEDICINE AND SCIENCE IN SPORTS AND EXERCISE, 2000, 32 (09) : S498 - S516
  • [2] Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO
  • [3] 2-S
  • [4] [Anonymous], 2021, Annual report on the ageing society [Summary] FY2021
  • [5] Sarcopenic obesity in ageing: cardiovascular outcomes and mortality
    Atkins, Janice L.
    Wannamathee, S. Goya
    [J]. BRITISH JOURNAL OF NUTRITION, 2020, 124 (10) : 1102 - 1113
  • [6] Sarcopenic Obesity and Risk of Cardiovascular Disease and Mortality: A Population-Based Cohort Study of Older Men
    Atkins, Janice L.
    Whincup, Peter H.
    Morris, Richard W.
    Lennon, Lucy T.
    Papacosta, Olia
    Wannamethee, S. Goya
    [J]. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2014, 62 (02) : 253 - 260
  • [7] An Overview of Sarcopenic Obesity
    Cauley, Jane A.
    [J]. JOURNAL OF CLINICAL DENSITOMETRY, 2015, 18 (04) : 499 - 505
  • [8] Associations of grip strength with cardiovascular, respiratory, and cancer outcomes and all cause mortality: prospective cohort study of half a million UK Biobank participants
    Celis-Morales, Carlos A.
    Welsh, Paul
    Lyall, Donald M.
    Steell, Lewis
    Petermann, Fanny
    Anderson, Jana
    Iliodromiti, Stamatina
    Sillars, Anne
    Graham, Nicholas
    Mackay, Daniel F.
    Pell, Jill P.
    Gill, Jason M. R.
    Sattar, Naveed
    Gray, Stuart R.
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2018, 361
  • [9] Asian Working Group for Sarcopenia: 2019 Consensus Update on Sarcopenia Diagnosis and Treatment
    Chen, Liang-Kung
    Woo, Jean
    Assantachai, Prasert
    Auyeung, Tung-Wai
    Chou, Ming-Yueh
    Iijima, Katsuya
    Jang, Hak Chul
    Kang, Lin
    Kim, Miji
    Kim, Sunyoung
    Kojima, Taro
    Kuzuya, Masafumi
    Lee, Jenny S. W.
    Lee, Sang Yoon
    Lee, Wei-Ju
    Lee, Yunhwan
    Liang, Chih-Kuang
    Lim, Jae-Young
    Lim, Wee Shiong
    Peng, Li-Ning
    Sugimoto, Ken
    Tanaka, Tomoki
    Won, Chang Won
    Yamada, Minoru
    Zhang, Teimei
    Akishita, Masahiro
    Arai, Hidenori
    [J]. JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION, 2020, 21 (03) : 300 - +
  • [10] What is dynapenia?
    Clark, Brian C.
    Manini, Todd M.
    [J]. NUTRITION, 2012, 28 (05) : 495 - 503